Health Condition 1: H041- Other disorders of lacrimal gland
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Palliative care patients Subjects with clinical symptoms of dry eye, OSDI between 13to32, Schirmer I test value between 5 - 15 mm Subjects of either gender, Age group above 18 to 80 years Subjects willing to participate for the study and have signed an informed consent who are under palliative care No prior treatment for dry eye with in the last 15 days
Exclusion criteria
Exclusion criteria: Subjects with dry eye due to systemic or auto immune disease confirmed through medical history or diagnostic testing. Subjects who suffer from aqueous deficiency dry eye Recent ocular surgery or trauma within the past 6months. Contact lens wearers Subject with a known allergy to ingredients in Durva Ghrita, as assessed by medical history or allergy testing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To introduce a drug from the field of Ayurveda to address medical issues in palliative care patients like dry eyeTimepoint: on the basis of clinical observation (subjective and objective parameters Schirmer test, OSDI questionnaire, Visual analogue scale (VAS)) before and after 14th day and on 28th day of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| To introduce a drug from the field of Ayurveda to address medical issues in palliative care patients like dry eyeTimepoint: Base line , 14th day & 28th day of treatment | — |
Countries
India
Contacts
Glocal college of Ayurvedic medical science and research centre